new psychoactive substances & early warning systems

42
New Psychoactive Substances & Early Warning Systems Dr David Caldicott (FCEM) Emergency Specialist, Nevill Hall Hospital, Abergavenny, Wales Co-Founder & Coordinator WEDINOS

Upload: others

Post on 03-Feb-2022

5 views

Category:

Documents


0 download

TRANSCRIPT

New Psychoactive Substances & Early Warning Systems

Dr David Caldicott (FCEM)

Emergency Specialist, Nevill Hall Hospital, Abergavenny, Wales

Co-Founder & Coordinator

WEDINOS

Nevill Hall Hospital,Abergavenny

A Candy Store?

Types of Drugs Involved…

• Natural– Kratom– Salvia – Hallucinogenic mushrooms – Cactus – JWH-018 (cannabinoid) – JWH-250 (cannabinoid) – Ayahuasca (active principle DMT) – Hawaiian baby woodrose (active

principle lysergamides)

• Synthetics– aminoindanes (MDAI, 5-IAI) – arylcyclohexylamines

(Methoxetamine) – benzofurans (6-APB, 5-APB) – cathinones (4-MEC, MDPV,

Methylone, Mephedrone, 3,4-DMMC)

– thiophenes (Methiopropamine) – benzoates (Dimethocaine) – cannabinoids (AM-2201, JWH-

122) – tryptamines (AMT) – aminotetralins (MDAT) – phenethylamines (4-FA) – GHB related (GBL, 1,4BD)

Dizzying array of products…

“If you can’t Measure it, you can’t Manage it…”

Drug Information Systems

• Many now in place globally e.g.– DAWN

– IDRS

– EMCDDA

• Different methodologies- different strengths & weaknesses

• Designed with different purposes in mind

• Designed with different drugs in mind

Are Current systems fit for Purpose in the era of Legal Highs?

Drug Abuse Warning Network

• Based in USA

• Harm-based information

• Uses a retrospective ED data extraction methodology from patients notes

• Sentinel monitoring hospitals- complex national extrapolation

• Dependent upon doctor’s documentation and patient’s information

Illicit Drug Reporting System• Based in Australia

• three components: – interviews with people who inject drugs (PWID) regularly; – interviews with key experts (KEs); – analysis and examination of indicator data sources related to illicit drugs( (price, purity, availability and patterns of use of heroin, methamphetamine, cocaine and cannabis).

• designed to be sensitive to trends

• Yearly reports, state and federal

European Monitoring Centre for Drugs and Drug Addiction

• Decentralized EU agency

• Established 1993, based in Lisbon

• Centralized collation of National collected data

• Produces succinct and insightful reports in timely fashion

• Capability to respond to rapidly emerging trends

Problems with measuring health impacts of legal highs

• Present with a set of symptoms, not name of drug

• ICD10 Coding for drug related problems

• No chemical standards

• Poorly understood metabolic pathways

Non-Toxicological Problems

• Assault

• Self Harm

• Rape & Sexual Assault

• IVDA-related

Behavioral & Social Problems

Haemorrhagic Cystitis

From Chu et al, BJU International, 102 (11), 1616-1622

From Raja et al, BJU International, 2011

What are we treating?

• What are the substances?

• Who is using them and why?

• How much medical harm are they causing?

WEDINOS

• Welsh Emergency Department Investigation of Novel Substances Group

• ‘Wedi nos’ is also Welsh for ‘after dark’

• 3 tiers of investigation…

– Identify products associated with harm

– Identify patterns of harmful use

– Develop acute brief interventions for consumers

Network of Monitoring Hubs

WEDINOS

• Identify products associated with Harm

WEDINOS

• Identify products associated with Harm

ED Amnesty Bins

Neo-organics

Alcohol vs Mephedrone

Alcohol vs Mephedrone

Recreational Drug Use- RAH

0

100

200

300

400

500

600

2000 2001 2002 2003

Alcohol

Everythingelse puttogether

Impact of legislation

From Wood, et al, Emerg Med J, 2011 in press

WEDINOS-Identifying patterns of harmful use

WEDINOS-Intervening with high risk patients

• Screening, Brief Interventions and Referral to Treatment (SBIRT) for young adults presenting at the Emergency Department (ED) with problems related to (poly)drug use

• 6 EDs, over 3 EU countries

• The partners involved in this project are: • VAD, Belgium (coordinator);

• Liverpool John Moores University, UK;

• Trimbos-Institute, The Netherlands;

• Irefrea, Spain;

• Eotvos Lorand University, Hungary;

• Dr. David Caldicott, UK and Msc Jan Krul, The Netherlands.

WEDINOS-Engagement with Consumers

• Critical to engage consumers in a language they understand

• Their involvement advances the data streams several steps

• Don’t get ‘nuthin’ fer nuthin’-need to decide what the consumers get for participating

Where do the Dangers Lie?

• Most of these drugs are not natural born killers

– No better or worse than others

– Much less common than the old favorites

• Danger lies in mutation rate and market

– Remember PMA? MPTP?

What of the Future?

• The future is not bright...

• Global economic crisis

• Sense of a shift in global drugs realpolitik?

• Need to add in monitoring systems that can cope with new markets…

A Novel Psychotropic

Substance

• WEDINOS Collaborative• Joe Donne (Data management, ABHB)• Mike Hemming (GIS Analysis, WAG IM&T)• Gareth Hughes -Graphic Design• Department of Public Health, Welsh Assembly Government

Thank You’s and Acknowledgements…

And not forgetting… The Daily Mail